NCT00916682

Brief Summary

This study seeks to provide point-of-care clinical diagnostic systems for the diagnosis of current disease status using saliva as a sample specimen.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
273

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2007

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

June 5, 2009

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 9, 2009

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2013

Completed
Last Updated

June 10, 2026

Status Verified

June 1, 2021

Enrollment Period

5.6 years

First QC Date

June 5, 2009

Last Update Submit

June 8, 2026

Conditions

Cystic Fibrosis

Outcome Measures

Primary Outcomes (1)

  • Salivary Biomarkers

    Biomarkers of inflammation in saliva

    Baseline

Study Arms (1)

Cystic Fibrosis

Eligibility Criteria

Age6 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects will be approached during their pulmonary clinic appointment or while they are inpatient at Children's Hospital, Boston.

You may qualify if:

  • or more years of age
  • confirmed Cystic Fibrosis

You may not qualify if:

  • Pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hosptital, Boston

Boston, Massachusetts, 02115, United States

Location

Related Links

MeSH Terms

Conditions

Cystic Fibrosis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Study Officials

  • Ahmet Uluer, DO

    Boston Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 5, 2009

First Posted

June 9, 2009

Study Start

November 1, 2007

Primary Completion

June 5, 2013

Study Completion

June 5, 2013

Last Updated

June 10, 2026

Record last verified: 2021-06

Locations

US(1)